- $103.66m
- $144.62m
- $198.68m
- 48
- 84
- 29
- 53
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 104 | 122 | 198 | 229 | 199 |
Cost of Revenue | |||||
Gross Profit | 10.8 | 33.2 | 64.3 | 57.8 | 24.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 119 | 105 | 167 | 226 | 226 |
Operating Profit | -15.6 | 16.8 | 31.7 | 2.81 | -27.5 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -23.5 | 7.72 | 31.8 | 4.04 | -35.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -27 | 6.76 | 22.6 | -2.23 | -32.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -27 | 6.76 | 22.6 | -1.45 | -30.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -27 | 6.76 | 22.6 | -1.45 | -30.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.504 | 0.11 | 0.389 | 0.112 | -0.355 |